Drug Carrier

Metformin hydrochloride (MTH) has been associated with poor/incomplete absorption (50–60%), low bioavailability, short half-life (0.4–0.5 h), high dosage and dose-related side effects....

Aim Evaluation of different polyhydroxy surfaces in SEDDS to overcome the limitations associated with conventional polyethylene glycol (PEG)-based SEDDS surfaces...

The size of nanocarriers determines the biological property of the materials, especially as it relates to intratumoral distribution. Previous research...

Atopic dermatitis (AD) is a chronic disease that affects the skin, and that is characterized by highly itchy inflammation, frequent...

Compared to oral and injectable administration, a dermal and transdermal drug delivery system that can deliver therapeutic molecules to desired...

Selective laser sintering (SLS) 3D printing is capable of revolutionising pharmaceutical manufacturing, by producing amorphous solid dispersions in a one-step...

Nose-to-brain drug delivery has been of great interest for the treatment of many central nervous system (CNS) diseases and psychiatric...

Pulmonary inhalation administration is an ideal approach to locally treat lung disease and to achieve systemic administration for other diseases....

During chronic treatment of diabetes mellitus, a few patients may need combination therapy with metformin hydrochloride (MH). Such combinations are available in...

Surgery is an important treatment for cancer; however, local recurrence following macroscopically-complete resection is common and a significant cause of...